D. C. Baumgart and W. J. Sandborn, Inflammatory bowel disease: clinical aspects and established and evolving therapies, Lancet, vol.369, pp.1641-1657, 2007.

A. Darfeuille-michaud, Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease, Gastroenterology, vol.115, pp.1405-1413, 1998.

J. P. Hugot, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, vol.411, pp.599-603, 2001.

A. L. Hart, Characteristics of intestinal dendritic cells in inflammatory bowel diseases, Gastroenterology, vol.129, pp.50-65, 2005.

L. Halme, Family and twin studies in inflammatory bowel disease, World J. Gastroenterol, vol.12, pp.3668-3672, 2006.

B. Sendid, Specific antibody response to oligomannosidic epitopes in Crohn's disease, Clin. Diag. Lab. Immunol, vol.3, pp.219-226, 1996.

S. Plevy, Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients, Inflamm. Bowel Dis, vol.19, pp.1139-1148, 2013.

S. Lesage, CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease, AJHG, vol.70, pp.845-857, 2002.

F. Seibold, Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease, Gastroenterology, vol.127, pp.1076-1084, 2004.

L. Choteau, Role of mannose-binding lectin in intestinal homeostasis and fungal elimination, Mucosal Immunol, 2015.

M. Matsushita and T. Fujita, Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease, J. Exper. Med, vol.176, pp.1497-1502, 1992.

K. Hajela, The biological functions of MBL-associated serine proteases (MASPs), Immunobiology, vol.205, pp.467-475, 2002.

W. I. Weis, K. Drickamer, and W. A. Hendrickson, Structure of a C-type mannose-binding protein complexed with an oligosaccharide, Nature, vol.360, pp.127-134, 1992.

D. Heja, Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2, Proc. Natl. Acad. Sci. USA, vol.109, pp.10498-10503, 2012.

M. Megyeri, Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway, J. Biol. Chem, vol.288, pp.8922-8934, 2013.

L. Jenny, J. Dobo, P. Gal, and V. Schroeder, MASP-1 of the complement system promotes clotting via prothrombin activation, Molec. Immunol, vol.65, pp.398-405, 2015.

A. Krarup, R. Wallis, J. S. Presanis, P. Gal, and R. B. Sim, Simultaneous activation of complement and coagulation by MBL-associated serine protease 2, PloS One, vol.2, p.623, 2007.

K. Takahashi, Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation, Immunobiology, vol.216, pp.96-102, 2011.

L. Bak-romaniszyn, Mannan-binding lectin deficiency in pediatric patients with inflammatory bowel disease, Scand. J. Gastroenterol, vol.46, pp.1275-1278, 2011.

F. Seibold, Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study, Inflamm. Bowel Dis, vol.13, pp.1077-1082, 2007.

S. Muller, Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens, Gut, vol.59, pp.1493-1500, 2010.

K. Uemura, L-MBP is expressed in epithelial cells of mouse small intestine, J. Immunol, vol.169, pp.6945-6950, 2002.

S. V. Petersen, S. Thiel, L. Jensen, R. Steffensen, and J. C. Jensenius, An assay for the mannan-binding lectin pathway of complement activation, J. Immunol. Methods, vol.257, pp.107-116, 2001.

R. G. Nielsen, Genetic polymorphisms of mannan binding lectin (MBL), serum levels of MBL, the MBL associated serine protease and H-ficolin in patients with Crohn's disease, Gut, vol.56, pp.311-312, 2007.

C. Hoffmann, Is there a role for mannan-binding lectin in the diagnosis of inflammatory bowel disease?, Immunogenetics, vol.62, pp.231-235, 2010.

G. Ambrus, Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments, J. Immunol, vol.170, pp.1374-1382, 2003.

J. S. Presanis, K. Hajela, G. Ambrus, P. Gal, and R. B. Sim, Differential substrate and inhibitor profiles for human MASP-1 and MASP-2, Molec. Immunol, vol.40, pp.921-929, 2004.

M. Papp, New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort, Am. J. Gastroenterol, vol.103, pp.665-681, 2008.

M. Ferrante, New serological markers in inflammatory bowel disease are associated with complicated disease behaviour, Gut, vol.56, pp.1394-1403, 2007.

A. Swale, Serum mannose-binding lectin concentration, but not genotype, is associated with Clostridium difficile infection recurrence: a prospective cohort study, Clin. Infect. Dis, vol.59, pp.1429-1436, 2014.

, Scientific RepoRts |, vol.6

A. M. Schoepfer, Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA), Am. J. Gastroenterol, vol.104, pp.2508-2516, 2009.

B. J. Kullberg, Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 crosstolerance to intestinal stimuli, Immunology, vol.123, pp.600-605, 2008.

N. Inohara, Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease, J. Biol. Chem, vol.278, pp.5509-5512, 2003.

E. Hoefkens, Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress, Autophagy, vol.9, pp.2046-2055, 2013.

M. L. Baptista, CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population, Inflamm. Bowel Dis, vol.14, pp.674-679, 2008.

M. Ningappa, NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome, Am. J. Gastroenterol, vol.106, pp.157-165, 2011.

S. Nikolaus and S. Schreiber, Diagnostics of inflammatory bowel disease, Gastroenterology, vol.133, pp.1670-1689, 2007.

M. S. Silverberg, Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology, Can. J. Gastroenterol, 2005.

B. Sendid, Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan, Clin. Vacc. Immunol, vol.15, pp.1868-1877, 2008.

S. Jawhara, Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3, J. Infect. Dis, vol.197, pp.972-980, 2008.

J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics, vol.21, pp.263-265, 2005.